RankAlpha logo

AMRZ

TentativeAI Memo

Amrize

As of 2026-10-01/Confidence medium
Open tickerBack to Memos
Data freshness
AI Memo
As of 2026-10-01 • Model: RankAlpha Sentiment Codex

Decision Panel

Action, confidence, horizon, and decision blockers at a glance.

Report quality notice
peer set is too generic or lacks enough direct operating comparators; memo remains a monitoring view with limited forward evidence and should not be standard-conviction
Action
—
Confidence
medium
Horizon
—
Key catalyst
Q3 results test the revised 2026 outlook • 2026-10-26
Base target: $39 / p=50% prob
Biggest risk
Cost inflation has already compressed margins despite sales growth. BofA downgraded AMRZ to Underperform on September 2 and reduced its target to $40 from $50, citing slower growth and pricing and roofing risks. BofA downgrade coverage
Invalidation
Break below $30 or thesis failure.
What would change my mind?
Q2 revenue rose 8.6%, supported by volumes and acquisitions, and management raised full-year revenue guidance. Better second-half price-cost performance and ASPIRE delivery could restore margin confidence. [#SEC-8K-2026-08-06] Amrize earnings release
Research note
Recommendation
—
Confidence
medium
As of
2026-10-01
Base target
$39
p=50%
Bull target
$47
p=25%
Bear target
$30
p=25%

Key bullets

Fast scan of bull, bear, and watch items

BullKey bullets
  • Second-half price-cost recovery and ASPIRE savings
  • Buyback and investment balance
  • Q2 revenue rose 8.6%, supported by volumes and acquisitions, and management raised full-year revenue guidance.
BearKey bullets
  • Building Envelope Q2 adjusted EBITDA declined 5.2% and segment margin fell 350 basis points year over year.
  • Amrize earnings release
  • Building Envelope leadership transition adds execution risk while margin recovery remains unproven.
WatchKey bullets
  • Q3 results test the revised 2026 outlook

Summary

High-level snapshot

Recommendation
-
Model confidence
medium
Timeframe
-
Asset
Equity
Trigger
-
Base case: $39 (p=50%)
Target spread vs base: +21% / -23%
Scenario probabilities
Bull Target: $47 (p=25%)Base Target: $39 (p=50%)Bear Target: $30 (p=25%)
Commentary
Recent analyst coverage is cautious: BofA's September downgrade and target cut weigh against the large upside implied by the packet's unverified target mean. No reliable social, options, short-interest or employee-sentiment readings were supplied; zero entries above denote unavailable data, not neutral measurements. A verified post-Q2 price-reaction attribution is also unavailable. BofA downgrade coverage
As of 2026-10-01 • Updated bi-weekly / post-earningsSource: Internal modelMethodology

Analyst Summary

Thesis highlights from the latest analysis

Bull Case
Q2 revenue rose 8.6%, supported by volumes and acquisitions, and management raised full-year revenue guidance. Better second-half price-cost performance and ASPIRE delivery could restore margin confidence. [#SEC-8K-2026-08-06] Amrize earnings release
Bear Case
Cost inflation has already compressed margins despite sales growth. BofA downgraded AMRZ to Underperform on September 2 and reduced its target to $40 from $50, citing slower growth and pricing and roofing risks. BofA downgrade coverage

Drivers

Scannable catalysts and supporting factors

  • Second-half price-cost recovery and ASPIRE savings
  • Buyback and investment balance

Scenarios

Bull Target (Scenario probability)
$47 / p=25% prob
Base Target (Scenario probability)
$39 / p=50% prob
Bear Target (Scenario probability)
$30 / p=25% prob
Analysis 2026-10-01 · RankAlpha Sentiment Codex
Analysis reference price unavailable. Targets are shown without scenario returns.

Sentiment & Exposure

News Sentiment (30d)
-0.30
Social Sentiment (7d)
0.00

Events

Other notable items detected

  • EVENT2026-10-26
    Q3 results test the revised 2026 outlook
    The company lists its Q3 earnings call for October 26–30. The key test is whether construction demand and pricing can support its revised $12.5–$12.7 billion revenue and $3.1–$3.2 billion adjusted EBITDA guidance despite fuel and freight inflation. [#SEC-8K-2026-08-06] Amrize earnings release IR calendar
    Prob 65.00% • Move 5.00% • Priced-in 50.00%
  • EVENT2026-10-30
    Building Envelope leadership and margin execution
    Mario Gross became Building Envelope president on September 11 after Jake Gosa gave notice. The next segment results will offer an early check on execution; the appointment itself does not establish a margin turnaround. [#8-K-2026-09-11] SEC filing
    Prob 50.00% • Move 3.00% • Priced-in 60.00%

Short-term Catalysts

Next few weeks

No short-term catalysts

Long-term Catalysts

Months to a year

  • Second-half price-cost recovery and ASPIRE savings
    2026-12-31
    Management expects second-half price-cost performance to improve and targets $80 million of 2026 ASPIRE savings. Q2 adjusted EBITDA margin nevertheless fell 80 basis points year over year, making delivery—not the target alone—the catalyst. [#SEC-8K-2026-08-06] Amrize earnings release
    Prob 55% • Move 6% • Priced-in 45%
  • Buyback and investment balance
    2026-12-31
    Amrize reported $197 million of Q2 repurchases under its $1 billion program while investing $241 million in quarterly capital expenditure. Subsequent disclosures can clarify how much cash remains available for repurchases, growth projects and acquisitions. [#SEC-8K-2026-08-06] Amrize earnings release
    Prob 60% • Move 3% • Priced-in 65%

Risks

  • Building Envelope Q2 adjusted EBITDA declined 5.2% and segment margin fell 350 basis points year over year. Amrize earnings release
  • Building Envelope leadership transition adds execution risk while margin recovery remains unproven. [#8-K-2026-09-11] SEC filing
  • Q2 adjusted EBITDA margin fell to 28.2% from 29.0% despite revenue growth; oil-driven freight, diesel and raw-material costs may outrun pricing. [#SEC-8K-2026-08-06] Amrize earnings release
  • The earnings release flags prior-period financial-statement revisions; monitor related disclosures without assuming a material restatement. Amrize earnings release

Peers

SymbolSummary
CRHNorth American aggregates, cement and building-materials operations make CRH a useful broad operating comparator, although its scale and product mix differ from Amrize. CRH Q2 release
EXPEagle Materials spans cement and aggregates alongside gypsum wallboard, providing a closer two-sided materials-and-envelope comparison; wallboard is not identical to Amrize's roofing portfolio. Eagle Materials FY2026 release
MLMMartin Marietta is another aggregates and heavy-materials operating comparator, but its portfolio is not a close match for Amrize's roofing exposure. Martin Marietta Q2 release
VMCVulcan is a direct construction-aggregates comparator for pricing, shipments and cost trends, but lacks Amrize's substantial Building Envelope business. Vulcan Q2 release

Sources

Internal and external references used in this analysis

  • Model source: RankAlpha Sentiment Codex
  • Analysis date: 2026-10-01